Internal link ProQR Announces a Proof-of-Concept Nasal Potential Difference Study of QR-010 is Open for Enrollment September 14, 2015 at 11:00 AM UTC
Internal link ProQR Announces Enrollment Has Started in Global Phase 1b Study of QR-010 in Cystic Fibrosis Patients June 26, 2015 at 11:54 AM UTC
Internal link ProQR to Present at the JMP Securities Life Science Conference June 16, 2015 at 11:00 AM UTC
Internal link ProQR Therapeutics Announces Results for the First Quarter of 2015 May 21, 2015 at 11:00 AM UTC
Internal link ProQR to Present at Two Upcoming Investor Conferences in May April 29, 2015 at 11:00 AM UTC
Internal link ProQR Therapeutics Announces Results for the Fourth Quarter and Full Year 2014 February 26, 2015 at 12:00 PM UTC
Internal link ProQR to Present at the 2015 Leerink Global Healthcare Conference February 04, 2015 at 12:00 PM UTC